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ABSTRACT
Background Recruitment to trials in primary care
is often diﬃcult, particularly when practice staﬀ
need to identify study participants with acute con-
ditions during consultations. The Scottish Acute
Recruitment Management Application (SARMA)
system is linked to general practice electronic medi-
cal record (EMR) systems and is designed to pro-
vide recruitment support to multi-centre trials by
screening patients against trial inclusion criteria and
alerting practice staﬀ if the patient appears eligible.
For patients willing to learn more about the trial, the
software allows practice staﬀ to send the patient’s
contact details to the research team by text message.
Aim To evaluate the ability of the software to
support trial recruitment.
Design of study Software evaluation embedded in
a randomised controlled trial.
Setting Five general practices in Tayside and Fife,
Scotland.
Methods SARMAwas used to support recruitment
to a feasibility trial (the Response to Oral Agents in
Diabetes, or ROAD trial) looking at users of oral
therapy in diabetes. The technical performance of
the software and its utility as a recruitment tool
were evaluated.
Results The software was successfully installed at
four of the ﬁve general practices and recruited 11 of
the 29 participants for ROAD (other methods were
letter and direct invitation by a practice nurse) and
had a recruitment return of 35% (11 of 31 texts sent
led to a recruitment). Screen failures were relatively
low (7 of 31 referred). Practice staﬀ members were
positive about the system.
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Introduction
Recruitment to trials is diﬃcult and primary care
studies face particular challenges.1,2 Reviews of re-
cruitment barriers have highlighted time, memory,
consent procedures and diﬃcult research protocols as
signiﬁcant barriers to recruitment trials.1–4 Systems
that reduce these barriers can be expected to have a
positive eﬀect on recruitment although rigorous evi-
dence in favour of particular interventions is sparse.5,6
As a consequencemany trialsmiss their recruitment
targets, which often leads to underpowered trials and
non-signiﬁcant results that are nevertheless unable to
rule out the possibility that the intervention being
evaluated may have an important beneﬁt. The wide-
spread use of EMRs in the UK and elsewhere7,8 oﬀers
the potential to electronically pre-screen patients based
on the content of themedical records. Although patients
have not usually provided consent for their records to
be used for research purposes, when a patient consults
a clinician the doctor or nurse has a legitimate right to
view the patient’s details and so can be notiﬁed before
or during the consultation of patients who may be
potentially eligible for studies. This avoids the potential
ethical dilemma summarised in Box 1. AUS study using
this sort of notiﬁcation system reported a signiﬁcant
increase in doctors’ participation in and recruitment
rates to an ongoing trial based in outpatient clinics.9 In
this paper we describe the performance of an SMS-
based system, the SARMA system, which is linked to
general practice EMRsystems and is designed to provide
recruitment support to multi-centre trials.
The SARMA system
SARMA is a small piece of software that is installed on
the desktop computer of every general practitioner
(GP) or other member of practice staﬀ who may see a
patient who is potentially eligible for a particular trial.
Box 2 gives some brief technical details. Screening
Box 1 Consent for consent
This ethical dilemma may be described as: in
order to determine whether a potential study
subject consents to their data being accessed to
determine whether they are eligible for a study, all
potentially eligible subjects would ﬁrst need to be
contacted to provide consent to allow access to
their records.11 In 2009 the Wellcome trust de-
veloped a series of overarching principles:12
Safeguarding patient conﬁdentiality
. Use best available technologies to ensure se-
curity
. Mechanisms for accreditation and account-
ability, including honorary contracts for re-
search staﬀwhen extracting data frompractices
Improving public awareness
. Transparency: ‘no surprises’
. National campaign to raise awareness
. Provision of information at local practice level
. Opportunity to opt out of use of identiﬁable
information
Role of GP as patient’s advocate
. Provide advice and feedback
. May need training, support and resources
Box 2 A summary of the technology
Language
SARMA is developed using Java.
History
SARMA was originally developed as an agent-
based system where each patient was represented
by a software agent, which performed data extrac-
tion and communication on behalf of patients
being screened for trial participation.
Current version
As requirements have evolved, the requirement
for (and consequent overhead of) an agent-based
systemhas becomeunnecessary. SARMAno longer
has any agent-based functionality.
SARMA is currently implemented as a stan-
dard piece of client software, which is installed on
each GP workstation. The software is conﬁgured
with the trial inclusion criteria and queries the
underlying database of the practice medical rec-
ord system to extract the clinical data needed to
screen the patient for the trial.
Conclusion An automated recruitment tool can
support primary care trials in Scotland and has the
potential to support recruitment in other jurisdic-
tions. It oﬀers a low-cost supplement to other trial
recruitment methods and is likely to have a much
lower screen failure rate than blanket approaches
such as mailshots and newspaper campaigns.
Keywords: computers, computerised medical rec-
ord systems, medical informatics, patient selection
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criteria for the trial are loadedwith the software, which
then communicates with the practice EMR system. The
screening criteria used by the SARMA system there-
fore have to be available in themedical records system;
these criteria may be the same as the trial inclusion
criteria if all this information exists in the EMR. The
software ﬁrst screens all patients due to attend a con-
sultation with the GP or nurse at the start of the day
and compares the patient’s EMR with the screening
criteria. When a patient meeting these criteria enters
the consultation, a pop-upwindow informs themem-
ber of practice staﬀ that the patient may be eligible.
The staﬀ member then has the opportunity to ask the
patient whether he or she would be willing to allow a
researcher to contact him or her to discuss taking part
in the trial. The GP or nurse may also choose to close
the pop-up, or ignore it.
The default implementation would present the
member of practice staﬀ with a pop-up window with
three buttons: ‘Accept’, ‘Decline’ or ‘Unsuitable’. If
the patient says ‘No’ to being contacted, the GP clicks
the ‘Decline’ button. If the patient says ‘Yes’, the
member of practice staﬀ clicks the ‘Accept’ button,
which will ﬁrst ask the member of practice staﬀ to
conﬁrm with the patient that the telephone number
held in the EMR is correct, and allow it to be changed
if it isn’t. The software will then send an SMS text
message to a member of the research team, which will
contain the patient’s name and telephone number. An
information sheet for the patient can also be printed. If
themember of practice staﬀ knows that a patient is not
suitable for the trial despite meeting the software’s
pre-screen criteria, he or she can click ‘Unsuitable’ and
SARMAwill record this to ensure that pop-ups do not
appear again for this patient. If the member of staﬀ
does not have the opportunity to, or does not wish to,
raise the trial during the consultation, the pop-up
window is automatically cleared when the patient leaves
the consultation. The software can be extended to
provide additional post-screening logic and interac-
tion alongwith the necessary pop-ups so that staﬀmay
be presented withmore than the default, three-button
pop-up.
We believe that SARMA addresses the following
known barriers to recruitment:
. Time Provision of full information on the trial,
checking of full eligibility and formal consent is
done outside the consultation by the research team.
Referring a patient to the research team is a matter
of pressing a button.
. Memory The member of practice staﬀ no longer
needs to remember the inclusion criteria, or indeed
that the trial is running. Once installed, the software
will remind the member of staﬀ whenever a poten-
tially eligible patient enters the consultation.
. Diﬃcult study protocol The bulk of the work for
referring a patient to the trial team is done by the
software and the research team. The member of
practice staﬀ need only raise the trial with the
patient and provide basic information, which can
either be displayed in the pop-up window for the
staﬀ member to refer to or printed for the patient.
Our pilot qualitative workwith patients demonstrated
that patients had no problems with their names and
contact numbers being sent to a research team so long
as it was their GP who had raised the trial in the ﬁrst
instance.10
Method
The technical performance of SARMAwas tested on a
test installation and at a single general practice in
Dundee over several months. We also did some qual-
itativeworkwith four general practices in Tayside; two
were urban and two were rural. Nine GPs, eight practice
nurses, three practice managers, one GP registrar, one
medical student and one visiting doctor took part in
the these focus groups. Eight patients took part in two
focus groups and four patients participated in one-to-
one interviews. Seven GPs responded to an email
discussion document about recruitment software.
This work conﬁrmed that the software was tech-
nically able to work and that general practice staﬀ and
patients were positive about the system so long as it
did not intrude into the consultation. Further testing
of the software required it to be used in a real trial. For
this we used the ROAD feasibility trial (www.nres.
npsa.nhs.uk/researchsummaries/?entryid29=24000
andp=2). Details of the ROAD feasibility trial are
given in Box 3.
Our evaluation had four components:
1 a review of technical challenges encountered during
the ROAD feasibility trial
2 a comparison of the software with ROAD’s other
recruitment methods
3 a comparison of the list of potential participants
identiﬁed by the software with clinic lists to see if
SARMA had identiﬁed all potentially eligible par-
ticipants
4 collating any feedback from general practice staﬀ
and patients on the software.
Five general practices took part in the ROAD trial: all
of them used the Vision (INPS, UK) EMR system.
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Results
Technical challenges
The software was successfully installed at four of the
ﬁve general practices. At the four practices using the
software, both GPs and practice nurses used the system.
An initial diﬃculty was that practice staﬀ forgot to
run the software so the system was modiﬁed to start
automatically when the desktop machine was switched
on.
Two other problems required more work. Firstly,
the time taken by SARMA to interrogate the patient’s
medical record was excessive (several minutes) and
required a signiﬁcant rewriting of the system’s code.
This issue was, however, completely resolved and the
software’s interrogation of the medical record is now
essentially instantaneous. The second problem was
that the software occasionally scrambled the on-screen
display of the medical record system’s appointments
book. The contents of the appointments book were
not aﬀected and refresh of the screen corrected the
display of the appointments. The problem was never-
theless an unacceptable side eﬀect. A software modi-
ﬁcation solved this problem at three of the four
practices; the problem persisted at the fourth practice
but only occurred very intermittently (i.e. once or
twice a week) andwas not felt by the practice staﬀ to be
a signiﬁcant problem. It remains unclear why this
problempersisted, orwhySARMAcouldnotbe installed
at the ﬁfth practice.
Box 3 The ROAD trial
The ROAD trial aims to establish a prospective study of incident users of oral therapy to investigate
phenotypic and pharmacogenetic determinants of response to oral hypoglycaemic agents in patients with
type 2 diabetes, and to compare time to treatment failure in patients randomised to second-line oral agents.
The aims of the feasibility trial were to assess recruitment methods, numbers of eligible patients and the trial
process and to further develop and evaluate the SARMA system. Diabetes drug naı¨ve patients with anHbA1c
7% were eligible to receive metformin (Cohort 1). Those receiving metformin or who were previously
intolerant of metformin were randomised at drug initiation to one of gliclazide, pioglitazone or sitagliptin
(Cohort 2).
Participants were recruited from hospital clinics and general practice by range of methods, one of which
was SARMA:
1 Patients having an HbA1c >7% were selected from practice records and invited by their GP to participate
in the study.
2 Incident cases were identiﬁed using SARMA.
3 Practices not using the software could manually refer interested and suitable participants during a
consultation.
4 Suitable patients attending for a routine hospital diabetic clinic appointment were approached by a
research nurse and asked if they would consider taking part.
The SARMA component identiﬁed patients by screening the following information from the electronic
medical record system:
Cohort 1:
Age 35–80, HbA1c >7% and <10%, no prescription for any diabetes therapy in previous six months, latest
eGFR (in preceding six months) >60 ml/min.
Cohort 2:
Age 35 and <80, HbA1c >7% and 9%, recent prescription for metformin (within the last six months),
latest eGFR >50ml/min, no recent prescription of potential interactingmedication (gemﬁbrozil, rifampicin,
miconazole, phenylbutaxone), no prescription of a loop diuretic (surrogate measure of heart failure), latest
ALT (if measured) 2.5 (upper limit of normal) and no history of oesteoporosis.
In addition to these screened criteria, the GP or nurse was asked a few questions (simply requiring yes/no
responses) once the pop-upwindowoccurred. ForCohort 1, this was to check that the patient had had at least
six weeks of diet and lifestyle intervention. For Cohort 2, this was to check if the patient was staying on
metformin (metformin tolerant) or changing to second line treatment (metformin intolerant); and given the
potential for randomisation to a thiazolidinedione the GP or nurse was asked to say if the patient had a
history of cardiac failure.
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Comparing SARMA with ROAD’s
other recruitment methods
Table 1 compares the alternative recruitmentmethods
used by the ﬁve general practices in the ROAD feas-
ibility trial. In summary, SARMA recruited 11 of the
29 participants recruited to ROAD, most of them to
the cohort of patients starting second line treatment.
There were 31 potential participants picked up by the
software and forwarded to the ROAD research nurse,
one of whom could not then be contacted (see Figure 1).
Table 1 Comparison of the recruitment methods used in the ROAD trial
Cohort 1 – metformin (n = 11) Cohort 2 – gliclazide, pioglitazone or sitagliptin
(n = 18)
Via initial letter = 2 recruited
10 letters sent
5 no response
3 said no
Via initial letter = 7 recruited
20 letters sent
8 yes (1 failed before screening due to recent
<HbA1c)
4 said no
8 no response
Via SARMA = 2 recruited
9 texts sent
4 not eligible (one due to mistake in the initial
coding of screening criteria, two because HbA1c
changed, 1 commenced on metformin by GP
prior to visit 1)
1 declined
2 changed their minds
Via SARMA = 9 recruited
22 texts sent
6 declined
1 uncontactable
3 not eligible (one due to mistake in the initial
coding of screening criteria, 2 because HbA1c
changed)
3 changed their minds
Via clinic = 2 recruited
4 identiﬁed
2 did not attend
Via clinic = 2 recruited
4 identiﬁed
2 changed their minds
Via practice nurse = 5 recruited Via practice nurse = 0 recruited
Figure 1 Overview of the text messages sent by the recruitment system
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Of particular importance is that 23 of the 30 (77%)
potential participants were conﬁrmed by the ROAD
research nurse (NS) as being eligible for the trial. The
reasons for exclusion of the remaining seven patients
were: one patient had osteoporosis (this was not part
of the software’s screening process but was part of the
full list of exclusion criteria for Cohort 2); one patient
had too low an eGFR (thiswas an error in the coding of
the screening criteria); four patients had an HbA1c
that had subsequently fallen above or below the
inclusion criteria (this could be avoided in future by
setting the screening criteria just within the inclusion
criteria limits) and one patient had been started on
metformin by their GP prior to the visit. In other words,
the number of screen failures is low; withmodiﬁcation
to the recruitment criteria such as the HbA1c limits,
screen failures in this study could have been reduced to
almost zero.We see this as a considerable advantage of
the SARMA system, where both the GP and research
team are only involved when there is a high likelihood
of patient eligibility. Of the 31 eligible patients, 14 said
no when asked by GP if they would be willing to be
contacted by the ROAD research team. Reasons for
sayingno included ‘prefers tried and testedmeds’, ‘wants
to improve diet’ and ‘work commitments’. Five patients
subsequently said no after speaking to the study’s
research nurse (NS). Adverse events listed on the patient
information sheet were cited as one reason for saying
no at this stage of recruitment.
The ﬂow of the 38 potential participants identiﬁed
by SARMA through to recruitment of 11 participants
is shown in Figure 1. For the ROAD trial, each par-
ticipating GP received about one pop-up window a
month, with the rate of recruitment being around 0.3
participants per month.
Comparing the list of potential
participants identiﬁed by SARMA
with clinic lists
Patient lists for diabetic clinics held at two general
practices were compared to the SARMA log ﬁle to
conﬁrm that all potentially eligible patients had been
identiﬁed by the software. Diabetic clinics held on two
separate days were checked; a summary is given in
Table 2. All potentially eligible patients were correctly
identiﬁed by the software.
Feedback from general practice staﬀ
Feedback from practice staﬀ was positive and often
focused on the lack of work required to use the software.
Two example quotes are given below.
Comment from a practice nurse:
‘I haven’t found the system any problem at all, being a
small practice, it didn’t ﬂag up often and it was easy to sign
into in the morning when the computer was switching
on.’
Table 2 A comparison of diabetic clinic patient lists with the SARMA log ﬁles
Practice 1 (nurse-led clinic) Practice 2 (GP-led clinic)*
Clinic 1 (28 April 2009)
 23 patients booked in
 16 patients attended
 15 patients not eligible for ROAD because
outside trial age or HbA1c ranges
SARMA identiﬁed the 1 eligible patient (Cohort 1)
and a text message was sent.
Clinic 1 (15 July 2009)
 14 patients booked in (4 by telephone)
 10 patients attended
 9 patients not eligible for ROAD because outside
trial age range or no recorded HbA1c
SARMA identiﬁed the 1 eligible patient (Cohort 2)
but text message was not sent (pop-up was closed
or ignored by GP).
Clinic 2 (20 May 2009)
 12 patients booked in
 12 patients attended
 10 patients not eligible for ROAD because
outside trial HbA1c range
SARMA identiﬁed the 2 eligible patients (Cohort 2)
but text messages were not sent (pop-up was closed
or ignored by clinic nurse).
Clinic 2 (20 August 2009)
 21 patients booked in (3 by telephone)
 18 patients attended
 16 patients not eligible for ROAD because
outside trial age range or no recorded HbA1c
SARMA identiﬁed the 2 eligible patients (Cohort 2).
A text message was sent for 1 patient but pop-up
was closed or ignored by GP for other patient.
* The software is currently not conﬁgured to work with telephone consultations.
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Comment from a GP:
‘I found SARMA really rather good and user friendly. The
only weakness was that I frequently forgot to log onto it. It
would be good if it would log in automatically when
starting up Vision and let you have the option to opt out.’
Only one patient made a comment when completing
the feedback questionnaire:
‘On the whole this was well coordinated. I felt that the
survey being oﬀered by your GP at consultation worked
well since they can clarify any concerns immediately and
then the wheels were in motion. I think a request letter is
too easy to ignore or forget. I also felt the study highly
motivational.’
Discussion
This work with SARMA has demonstrated that re-
cruitment to primary care trials can be supported by
software that screens patient data held in EMR systems
and alerts the GP or other member of practice staﬀ to
potentially eligible patients. Practice staﬀ need no longer
remember either the trial or its inclusion criteria when
a potentially eligible patient presents. The software
could support trials in other ways. It could indepen-
dently record the number of eligible patients presented
and recruited, which would provide important infor-
mation about case mix in trials, for example, whether
patients in the trial had a diﬀerent disease severity
compared to those not taking part. The software could
also be used to run through practice records while
planning a trial to get better estimates of the likely
number of eligible participants and could, therefore,
enable trialists to make more informed decisions about
the number of practices needed for a given trial.
The use of text messaging makes it easy for practice
staﬀ to refer patients to the research team. However, it
would be possible to generate emails instead, which
may be preferable in some trials. A particular advan-
tage for a trial like ROAD is that the number of screen
failures was low (23%), and with minor code correc-
tions and adjustment to the screening criteria could be
reduced to close to zero. This compares favourably with
a similar study described by Embi and colleagues;9
although referrals in that study increased by a factor of
ten, recruitment increased by a factor of only two
because of screen failures. This is, of course, depen-
dent on the quality of data held in the medical record
system. If crucial inclusion criteria were not available
to SARMA then screen failures could be expected to be
higher. For four of the ﬁve practices involved in ROAD,
using SARMA was unobtrusive and trial participants
were recruited with little eﬀort required from practice
staﬀ. Practice staﬀ involved in the ROAD trial were
very positive about the software.
Some challenges remain. It is still not clear why the
ﬁfth practice was unable to use SARMA, although we
continue to work on this. The software is currently
only able to operate with the Vision medical record
system. Modiﬁcation to enable it to work with other
medical record systems is not expected to be onerous
(especially for the Scottish GPASS system) but needs
to be undertaken before this recruitment tool can be
widely used in Scotland-wide trials. It will also operate
throughout the UK as the clinical computing systems
used in Scottish practices are subject to the same
requirements for accreditation as those in England,
Wales and Northern Ireland.13 Increasing interoper-
ability of electronic records in Europe should allow
recruitment systems to be used more widely in the
near future.14,15 In the USA such tools could avoid the
diﬃculties experienced by researchers as a result of the
1996 Health Insurance Portability and Accountability
Act.16
More discussion with practice staﬀmay be required
to discover why the pop-upwindow is closed or ignored
so often (see Table 2), although there may be legit-
imate reasons (e.g. lack of time in the consultation) for
ignoring a pop-up. Indeed, the fact that practice staﬀ
can ignore the pop-up may make it easier for them to
agree to having the software installed. Like other trial
software and procedures, training will be necessary to
support practice staﬀ in their use of automated re-
cruitment software such as SARMA. The software is
mostly invisible so any training will be linked to the
pop-up screens and will almost certainly be less time-
consuming and costly than the training required for
more traditional recruitment methods that require
practice staﬀ to remember and apply inclusion criteria,
or obtain informed consent. That about one-third of
participants in the ROAD trial were recruited via the
software suggests that the system is likely to comp-
lement other recruitment strategies rather than be a
trial’s sole recruitment strategy. However, given that
SARMA needs no attention once installed, it is a low-
cost way of delivering an additional stream of trial
participants.
Conclusions
SARMA can support recruitment to primary care
trials in Scotland and has the potential to support
recruitment in other jurisdictions. It is speciﬁcally
designed to make it easy for practice staﬀ to refer
patients to the research team, transferring most of the
work of recruiting a participant away from the prac-
tice. Finally, it oﬀers a low-cost supplement to other
trial recruitment methods and is likely to have a much
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lower screen failure rate than blanket approaches such
as mailshots and newspaper campaigns.
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